Below are the most recent publications written about "Hypertension, Pulmonary" by people in Profiles.
-
Pya Y, Bekbossynova M, Medressova A, Latremouille C, Jansen P, Tauyekelova A, Kaliyev R, Jetybayeva S, Ziegler LA, Rajapreyar I, Eduardo Rame J. Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart. J Heart Lung Transplant. 2025 Jul; 44(7):1161-1164.
-
Hayes D, Jennerich AL, Coleman RD, Abston E, Adamson GT, Berger JT, Cohen SP, Cooper DS, Eghtesady P, Fynn-Thompson F, Grady RM, Hon SM, Hoopes CW, Jewell T, Lewthwaite H, Liu MF, McGiffin DC, Mullen MP, Qureshi AM, Morales DLS. Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2025 Feb; 211(2):157-173.
-
Geller A, Martinez Manzano JM, Jarrett SA, Wattanachayakul P, Malin J, Leguizamon R, John TA, Khan R, McLaren I, Prendergast A, Lo KB, Witzke C, Eiger G. Major adverse cardiovascular outcomes within distinct pulmonary hypertension patterns in advanced chronic kidney disease: A retrospective cohort analysis. Respir Med. 2024 10; 232:107743.
-
Tao R, Dharmavaram N, El Shaer A, Heffernan S, Tu W, Ma J, Garcia-Arango M, Baber A, Dhingra R, Runo J, Masri SC, Rahko P, Raza F. Relationship of TAPSE Normalized by Right Ventricular Area With Pulmonary Compliance, Exercise Capacity, and Clinical Outcomes. Circ Heart Fail. 2024 May; 17(5):e010826.
-
Warner ED, Corsi DR, Jimenez D, Bierowski M, Brailovsky Y, Oliveros E, Alvarez RJ, Kumar V, Bhardwaj A, Rajapreyar IN. Determinants of pulmonary hypertension in patients with end-stage kidney disease and arteriovenous access. Curr Probl Cardiol. 2024 Apr; 49(4):102406.
-
Katz MG, Hadas Y, Shtraizent N, Ravvin S, Madjarov JM, Eliyahu E. Unilateral Lung Removal in Combination with Monocrotaline or SU5416 in Rodents: A Reliable Model to Mimic the Pathology of the Human Pulmonary Hypertension. Methods Mol Biol. 2024; 2803:173-185.
-
Rochester CL, Alison JA, Carlin B, Jenkins AR, Cox NS, Bauldoff G, Bhatt SP, Bourbeau J, Burtin C, Camp PG, Cascino TM, Dorney Koppel GA, Garvey C, Goldstein R, Harris D, Houchen-Wolloff L, Limberg T, Lindenauer PK, Moy ML, Ryerson CJ, Singh SJ, Steiner M, Tappan RS, Yohannes AM, Holland AE. Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2023 08 15; 208(4):e7-e26.
-
Katz MG, Hadas Y, Vincek A, Freage-Kahn L, Shtraizent N, Madjarov JM, Pastuszko P, Eliyahu E. Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction. Respir Res. 2023 Aug 11; 24(1):197.
-
Gotsman I, Abu Ghosh Z, Zwas DR, Amir O, Leibowitz D. Pulmonary Hypertension Severity in Heart Failure: Clinical Characteristics and Impact on Outcome. Am J Cardiol. 2023 10 01; 204:29-31.
-
Morgan RW, Reeder RW, Ahmed T, Bell MJ, Berger JT, Bishop R, Bochkoris M, Burns C, Carcillo JA, Carpenter TC, Dean JM, Diddle JW, Federman M, Fernandez R, Fink EL, Franzon D, Frazier AH, Friess SH, Graham K, Hall M, Hehir DA, Himebauch AS, Horvat CM, Huard LL, Maa T, Manga A, McQuillen PS, Meert KL, Mourani PM, Nadkarni VM, Naim MY, Notterman D, Page K, Pollack MM, Sapru A, Schneiter C, Sharron MP, Srivastava N, Tabbutt S, Tilford B, Viteri S, Wessel D, Wolfe HA, Yates AR, Zuppa AF, Berg RA, Sutton RM. Outcomes and characteristics of cardiac arrest in children with pulmonary hypertension: A secondary analysis of the ICU-RESUS clinical trial. Resuscitation. 2023 09; 190:109897.